Olema Pharmaceuticals
Stock Forecast, Prediction & Price Target
Olema Pharmaceuticals (OLMA) stock Price Target by analysts
$27
Potential upside: 390.01%
Olema Pharmaceuticals price prediction
What is Olema Pharmaceuticals stock analysts` prediction?
Olema Pharmaceuticals stock forecast: Based on 1 Wall Street analysts` predicted price targets for Olema Pharmaceuticals in the last 3 months, the avarage price target is $27, with a high forecast of $NaN. The average price target represents a 390.01% change from the last price of $5.51.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Olema Pharmaceuticals stock Price Target by analysts
Full breakdown of analysts given Olema Pharmaceuticals price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Richard Law Goldman Sachs | 0% 0/2 | 11 months ago | $27 390.01% upside | $11.91 | StreetInsider | Previous targets (1) |
Emily Bodnar H.C. Wainwright | 0% 0/1 | over 1 year ago | $30 444.46% upside | $9.85 | StreetInsider | Previous targets (0) |
Richard Law Goldman Sachs | 0% 0/2 | over 1 year ago | $24 335.57% upside | $10.89 | StreetInsider | Previous targets (1) |
Olema Pharmaceuticals Financial Estimates
Olema Pharmaceuticals Revenue Estimates
Olema Pharmaceuticals EBITDA Estimates
Olema Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $5.83M Low: $5.83M High: $5.83M avg. 0% | Avg: $34.91M Low: $34.91M High: $34.91M avg. 498.24% | Avg: $283.12M Low: $283.12M High: $283.12M avg. 710.93% |
Net Income
% change YoY
| $-70.88M N/A | $-102.58M -44.71% | $-96.65M 5.78% | Avg: $-159.69M Low: $-144.02M High: $-91.39M avg. -65.21% | Avg: $-175.94M Low: $-142.52M High: $-90.49M avg. -10.17% | Avg: $-113.87M Low: $-113.87M High: $-113.87M avg. 35.27% | Avg: $6.63M Low: $6.63M High: $6.63M avg. 105.82% |
EBITDA
% change YoY
| $-71.09M N/A | $-106.98M -50.48% | $-104.58M 2.24% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.79 N/A | -$2.56 -43.01% | -$2.14 16.40% | Avg: -$2.53 Low: -$3.18 High: -$2.02 avg. -18.17% | Avg: -$2.65 Low: -$3.15 High: -$2 avg. -4.91% | Avg: -$2.52 Low: -$2.52 High: -$2.52 avg. 5.14% | Avg: $0.15 Low: $0.15 High: $0.15 avg. 105.82% |
Operating Expenses
% change YoY
| $71.49M N/A | $106.98M 49.65% | $104.96M -1.89% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Olema Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.42% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -144.02M, average is -159.69M and high is -91.39M.
What is Olema Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 302.29% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Olema Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 21.97% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$3.18, average is -$2.53 and high is $-2.02.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Olema Pharmaceuticals stock. The most successful analyst is Richard Law.